NCT07521865 · ACTIVE NOT RECRUITING
Remote Technologies in Early Stages of Alzheimer's Disease
This trial is testing a tablet-based brain training app for people who already have Mild Cognitive Impairment or early Alzheimer's dementia. Researchers want to know whether the app is practical, acceptable, and easy to use — not whether it slows or stops disease. It is a small feasibility study of 36 people over two weeks, meaning it is an early-stage test of whether the concept even works logistically, not a proof of benefit.
Eligibility criteria
Participants and study partners fulfilling all the following inclusion criteria are eligible for the study: • Informed Consent as documented by signature Study partners: • Native or fluent German speaker Participants: * Are able to give their consent to participate in the study * Age between 70 and 95 years * Native or fluent German speaker * Normal or corrected to normal vision and hearing * Ability to visit the study location repeatedly * MoCA score > 11 Exclusion Criteria: * Substance abuse * Severe neurological or psychiatric conditions (of note: patients with mild depressive symptoms not fulfilling the criteria for major depressive disorder will be recruited into the sample to better represent clinical reality)
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-04-13